Chemotherapy, Stem Cell Transplantation, and Graft-Versus-Host-Disease Prevention in Treating Patients With Refractory or Relapsed Hematologic Cancer, Myelodysplastic Syndrome, or Myeloproliferative Disorder
This study is ongoing, but not recruiting participants.
Study NCT00055744
Information provided by National Cancer Institute (NCI)
First Received: March 6, 2003
Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
